Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Read Article
News
2024
2023
Archive
Search news articles
May 24, 2017
APREA THERAPEUTICS ANNOUNCES FIRST PATIENTS ENROLLED IN PHASE IB/II CLINICAL STUDY OF APR-246 FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME
May 16, 2017
SCIENTIST.COM RAISED $24 MILLION IN EQUITY FINANCING CO-LED BY LEERINK TRANSFORMATION PARTNERS AND 5AM VENTURES.
May 12, 2017
THE AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE PUBLISHES STUDY OF SPYRYX BIOSCIENCES’ SPX-101, A NOVEL ENAC-TARGETED THERAPEUTIC FOR CYSTIC FIBROSIS THAT RESTORES MUCUS TRANSPORT
April 25, 2017
PHASERX RECEIVES POSITIVE OPINION FOR ORPHAN DRUG DESIGNATION FOR PRX-OTC FROM EUROPEAN MEDICINES AGENCY
April 20, 2017
AUDENTES THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK
April 20, 2017
FIRST INSTALLATION OF THE WORLD’S MOST RESPONSIVE SMART-TINTING GLASS UNVEILED IN SAN FRANCISCO
April 12, 2017
MILLENDO THERAPEUTICS APPOINTS MARY LYNNE HEDLEY, PH.D. AND CAROLE NUECHTERLEIN, J.D. TO BOARD OF DIRECTORS
April 12, 2017
NOHLA THERAPEUTICS ANNOUNCES COLLABORATION WITH UNIVERSITY OF CALIFORNIA, DAVIS TO OPTIMIZE MANUFACTURING PROCESS AND SUPPLY CELL THERAPY PRODUCT FOR CLINICAL TRIALS
April 5, 2017
SPYRYX BIOSCIENCES PRESENTS DATA AND CORPORATE UPDATE AT TWO RECENT CONFERENCES IN SUPPORT OF CLINICAL CANDIDATE FOR CYSTIC FIBROSIS
April 4, 2017
CARB-X INJECTS UP TO $48 MILLION TO ACCELERATE FIRST POWERED BY CARB-X PORTFOLIO OF DRUG DISCOVERY AND DEVELOPMENT PROJECTS TO TACKLE ANTIBIOTIC RESISTANCE
« Previous Page
1
…
70
71
72
73
74
…
103